Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects

Kidney International

Volumn 77, Issue 11, 2012, Pages 943-945

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PARICALCITOL; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR AGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AUTACOID; BIOLOGICAL MARKER; CALCITRIOL RECEPTOR; CREATININE; ERGOCALCIFEROL; LOSARTAN; SCLEROPROTEIN; VITAMIN;

ALBUMINURIA; CELL LOSS; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; FIBROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INHIBITION KINETICS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANIMAL; BLOOD; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; GLOMERULUS; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PATHOLOGY; UREA NITROGEN BLOOD LEVEL; URINE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ERGOCALCIFEROLS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY GLOMERULUS; LOSARTAN; MICE; RECEPTORS, CALCITRIOL; RENIN-ANGIOTENSIN SYSTEM; VITAMINS;

EID: 77955881910     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.77     Document Type: Note

References (15)

1. Hess AF. The prevention and cure of rickets by sunlight. Am J Public Health (NY) 1992 ; 1 2 : 104-107.
2. Agarwal R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 2009; 4 : 1 523-1 528.
3. Li YC. Renoprotective effects of vitamin D analogs. Kidney Int advance online publication, 27 May 2009, doi:10.1038/ki.2009.175.
4. Li YC, Kong J, Wei M e t al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the reninangiotensin system. J Clin Invest 2002; 110: 229-238. (Pubitemid 34787360)
5. Li YC, Qiao G, Uskokovic M e t al. Vitamin D: a negative endocrine regulator of the reninangiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90: 387-392. (Pubitemid 38844316)
6. Zhang Z, Sun L, Wang Y e t al. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int 2008; 7 3: 1 63-1 71.
7. Deb DK, Sun T, Wong KE et al. Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. K idney Int 2010; 7 7: 1 000-1009.
8. Zhang Z, Zhang Y, Ning G e t al. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci USA 2008; 1 05: 1 5896-1 5901.
9. Bodyak N, Ayus JC, Achinger S e t al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007 ; 1 04 : 16810-16815. (Pubitemid 350210947)
10. Agarwal R, Acharya M, Tian J e t al. A ntiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 2005; 6 8: 2 823-2 828. (Pubitemid 43251029)
11. Agarwal R, Panesar A, Lewis RR. Dipstick proteinuria: can it guide hypertension management? Am J Kidney Dis 2002 ; 39 : 1190-1195. (Pubitemid 34591934)
12. Alborzi P, Patel NA, Peterson C e t al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. H ypertension 2008; 5 2: 249-255.
13. Szeto CC, Chow KM, Kwan BC e t al. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. A m J Kidney Dis 2008; 5 1: 724-731. (Pubitemid 351626254)
14. Fishbane S, Chittineni H, Packman M e t al. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis 2009; 5 4: 647-652.
15. Lambers Heerspink HJ, Agarwal R, Coyne DW et al. The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) study: study design and baseline characteristics. Am J Nephrol 2009; 3 0: 280-286.